Part of the Handbook of Experimental Pharmacology book series (HEP, volume 167)
Protein Kinase Inhibitors for the Treatment of Disease: The Promise and the Problems
KeywordsProtein Phosphatase Protein Tyrosine Phosphatase Human Clinical Trial Protein Kinase Inhibitor Specific Protein Kinase
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Unable to display preview. Download preview PDF.
- Elchebly M, Payette P, Michaliszyn E, Cromlish W, Collins S, Loy AL, Normandin D, Cheng A, Himms-Hagen J, Chan CC, Ramachandran C, Gresser MJ, Tremblay ML, Kennedy BP (1999) Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase 1B gene. Science 282:1544–1548Google Scholar
- Kellie S (2003) Protein tyrosine phosphatases: potential roles in disease. In: Watling KJ (ed) Celltransmissions. Sigma-Aldrich, St Louis, pp 3–8Google Scholar
- Ring DB, Johnson KW, Henriksen EJ, Nuss JM, Goff D, Kinnick TR, Ma ST, Reeder JW, Samuels I, Slabiak T, Wagman AS, Hammond M-EW, Harrison SD (2003) Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilisation in vitro and in vivo. Diabetes 52:588–595PubMedGoogle Scholar
© Springer-Verlag 2005